Treasury shares issued

Summary by AI BETAClose X

Science Group plc announced the issuance of 39,000 treasury shares on June 1, 2026, at a price of 1 pence per share to settle the exercise of share options. Following this transaction, the total number of ordinary shares in issue, excluding treasury shares, stands at 40,997,593, with the company holding 5,188,281 shares in treasury. This updated share count of 40,997,593 will serve as the denominator for shareholders to determine their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

Science Group PLC
02 June 2026
 

 

2 June 2026

 

Science Group plc

(the "Company" or "Science Group")

 

Treasury shares issued

 

Science Group plc (AIM:SAG) announces that on 1 June 2026 the Company issued 39,000 treasury shares at a price of 1 pence per share in settlement of the exercise of share options.

 

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 40,997,593.  Science Group holds 5,188,281 shares in treasury. 

 

The figure of 40,997,593 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.

 

 

- Ends -

 

For further information:

Science Group plc


Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 


Panmure Liberum Limited (Nomad and Joint Broker)


Nicholas How, Rupert Dearden

Tel: +44 (0) 20 3100 2000



Peel Hunt LLP (Joint Broker)


Neil Patel, Benjamin Cryer, Kate Bannatyne

Tel : +44(0)20 7418 8900


 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings